- Federal agenciesMay lead to clearer federal guidance and updated State Medicaid toolkits that encourage broader Medicaid coverage of re…
- Potential benefitSupporters could argue expanded use of remote physiologic monitoring might improve maternal and child health outcomes b…
- Potential benefitCould reduce patient travel and logistical burdens for low‑income Medicaid enrollees by promoting home-based monitoring…
Connected MOM Act
Referred to the House Committee on Energy and Commerce.
This bill (Connected MOM Act) requires the Secretary of Health and Human Services to produce a report to Congress within 18 months describing authorities and State practices for covering remote physiologic monitoring devices under State Medicaid programs, identifying limitations and barriers to coverage, and assessing impacts on maternal and child health outcomes. The report must include recommendations, as appropriate, for addressing barriers to coverage of devices such as pulse oximeters, blood pressure cuffs, scales, and blood glucose monitors for pregnant and postpartum women enrolled in Medicaid.
Scope and next steps: liberals push for follow-up funding/mandates to expand coverage; conservatives want to ensure the report does not become a de facto federal mandate.
Relative to its intended legislative type, this bill is a focused reporting requirement directing the Secretary of HHS to analyze Medicaid coverage of remote physiologic monitoring devices for pregnant and postpartum women and to update State-focused resources.
This bill (Connected MOM Act) requires the Secretary of Health and Human Services to produce a report to Congress within 18 months describing authorities and State practices for covering remote physiologic monitoring devices under State Medicaid programs, identifying limitations and barriers to coverage, and assessing impacts on maternal and child health outcomes.
The report must include recommendations, as appropriate, for addressing barriers to coverage of devices such as pulse oximeters, blood pressure cuffs, scales, and blood glucose monitors for pregnant and postpartum women enrolled in Medicaid.
Within six months after the report is submitted, the Secretary must update State Medicaid resources (for example, telehealth toolkits) to be consistent with the report’s recommendations.
On substance the bill is low-risk, technical, and broadly noncontroversial—traits that improve its prospects. However, many narrowly focused reporting or guidance bills nonetheless fail to clear committees or floor schedules unless attached to larger, higher-priority legislation. Because this bill neither creates major spending nor significant political controversy, its passage likelihood depends heavily on legislative calendar space and whether it is folded into a larger health/telehealth/maternal health package.
Relative to its intended legislative type, this bill is a focused reporting requirement directing the Secretary of HHS to analyze Medicaid coverage of remote physiologic monitoring devices for pregnant and postpartum women and to update State-focused resources. It is clear in purpose, assigns responsibility, and sets deadlines, but leaves out definitional, methodological, and resourcing details.
Scope and next steps: liberals push for follow-up funding/mandates to expand coverage; conservatives want to ensure the report does not become a de facto federal mandate.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- StatesCritics may note that the bill does not provide funding for states to acquire devices or implement coverage changes, so…
- StatesAdministrative costs and staff time will be required at HHS to compile the report and update resources, and states may…
- Potential burdenExpanded reliance on remote monitoring raises privacy and data security concerns because device data are often transmit…
Why the argument around this bill splits.
Scope and next steps: liberals push for follow-up funding/mandates to expand coverage; conservatives want to ensure the report does not become a de facto federal mandate.
A mainstream progressive would likely view this bill positively as a targeted, pragmatic step toward reducing maternal morbidity and mortality among Medicaid-enrolled pregnant and postpartum women, especially in underserved and rural communities.
They would see value in federal leadership that documents barriers and produces actionable recommendations to expand access to remote monitoring technologies that can improve prenatal and postpartum care.
Because the bill is a report-plus-toolkit approach rather than an immediate funding or mandate vehicle, progressives may press for stronger follow-up (funding, mandatory coverage, equity safeguards) but still support the statutory requirement for analysis and guidance.
A pragmatic moderate would generally view the bill as a sensible, low-risk federal step: collect evidence, document state practices, and update guidance before proposing policy changes.
They would appreciate the measured approach (report then toolkit) and see potential to improve maternal outcomes through better use of remote monitoring while avoiding immediate unfunded mandates.
However, they will look for cost estimates, clear metrics, and attention to unintended consequences like increased administrative burden or uneven state implementation.
A mainstream conservative would likely be skeptical about federal involvement in state Medicaid program design but may view this bill as relatively modest because it only requires reporting and updating guidance rather than mandating coverage or funding.
They would be concerned about potential federal pressure on states to expand coverage, increased Medicaid costs, and regulatory creep that could follow the recommendations.
Some conservatives might accept the bill as an information-gathering step if it remains non-binding, includes cost-neutral recommendations, and respects state control.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On substance the bill is low-risk, technical, and broadly noncontroversial—traits that improve its prospects. However, many narrowly focused reporting or guidance bills nonetheless fail to clear committees or floor schedules unless attached to larger, higher-priority legislation. Because this bill neither creates major spending nor significant political controversy, its passage likelihood depends heavily on legislative calendar space and whether it is folded into a larger health/telehealth/maternal health package.
- No cost estimate or appropriation is included; the administrative burden and resource needs for HHS to produce the report and update toolkits are unspecified.
- The bill's ultimate traction depends on committee priorities and whether it will be considered as a standalone bill or bundled into broader legislation—both unknown from the text.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Scope and next steps: liberals push for follow-up funding/mandates to expand coverage; conservatives want to ensure the report does not bec…
On substance the bill is low-risk, technical, and broadly noncontroversial—traits that improve its prospects. However, many narrowly focuse…
Relative to its intended legislative type, this bill is a focused reporting requirement directing the Secretary of HHS to analyze Medicaid coverage of remote physiologic monitoring devices for pregnant and postpartum wo…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.